ERBB2 and breast carcinoma: Jacot et al. assessed 155 patients with sporadic breast cancers which were matched for TNM status and found BRCA1 promoter methylation in 29% of TNBC and only in 5 and 2% of ER-positive and HER2-positive breast cancers respectively [30].